Equities

Granules India Ltd

GRANULES:NSI

Granules India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)540.40
  • Today's Change-3.85 / -0.71%
  • Shares traded1.14m
  • 1 Year change+62.67%
  • Beta0.5661
Data delayed at least 15 minutes, as of Sep 20 2024 08:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Granules India Ltd's net income fell -21.54% from 5.17bn to 4.05bn despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 24.86% to 27.10%.
Gross margin56.89%
Net profit margin10.47%
Operating margin16.33%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, Granules India Ltd increased its cash reserves by 30.71%, or 895.43m. The company earned 4.39bn from its operations for a Cash Flow Margin of 9.75%. In addition the company generated 76.64m cash from financing while 3.60bn was spent on investing.
Cash flow per share28.99
Price/Cash flow per share18.70
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Granules India Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -20.44%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.51%
Div growth rate (5 year)8.45%
Payout ratio (TTM)7.39%
EPS growth(5 years)12.51
EPS (TTM) vs
TTM 1 year ago
13.77
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.